We are very excited to celebrate our researchers and the awards and honors they are given!
Read more
[ultimate_heading main_heading=”Latest” alignment=”left” main_heading_font_family=”font_family:|font_call:” main_heading_style=”font-weight:900;” main_heading_font_size=”desktop:44px;” sub_heading_font_family=”font_family:|font_call:” sub_heading_style=”font-weight:700;” sub_heading_font_size=”desktop:20px;” main_heading_margin=”margin-bottom:30px;”]Recent news and stories from the Mass General Research Institute.[/ultimate_heading]
A new team research effort seeks to shed light on how mothers pass immunity to their babies during pregnancy and lactation.
Read more
Read more
Mass General researchers are testing how medical marijuana usage impacts mental health outcomes.
Read more
Read more
Health advocates hope to gain approval for an anatomically correct kidney emoji that could be used to improve patient-provider communication.
Read more
Read more
Emily is the communication specialist for the Ragon Institute of MGH, Harvard and MIT, where she combines her love for science and writing.
Read more
Read more
The good news is that most strokes are preventable, treatable and beatable, says Natalia Rost, MD, MPH, Chief of the Stroke Division.
Read more
Read more
Scovil was one of the first nurses to be formally trained at Mass General and was a prolific author and advice columnist for women.
Read more
Read more
Dr. Tohyama is studying the brain mechanisms of patients with chronic pain and loves using her creativity to answer research questions.
Read more
Read more
TEMPOS is a user-friendly rating scale that can be used to assess adherence to reporting recommendations.
Read more
Read more
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
Read more
Read more